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Supplementary Figure 1: Bulge stem cells are heterogenous in their clock.
Immunohistochemistry of venus-GFP in Per1-venus mouse backskin at different hair cycle stages shows 
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Supplementary Figure 2: Per1-venus expression is homogeneous in the basal epidermis during anagen.
a,b, Quantification of venusbright and venusdimFHOOVLQWKHĮLQWHJULQbright/CD34- epidermal population of Per1-venus 
mice at different stages of the hair cycle (P19, P22, P25, P28 and P31) by FACS showed no changes in the 
percentage of venusbright and venusdimFHOOVLQWKHEDVDOHSLGHUPLVPHDQVHPQ
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Supplementary Figure 3: Dynamic changes of Clock gene expression during the hair cycle in Per1-GFP 
reporter mice. 
a, Whole mount immunostaining of mouse tailskin from Per1-GFP mice at different stages of the hair cycle (from 
P19 to P31) showed a steady increase of GFPbright cells in the bulge compartment during anagen. Upper panel, 
DQWL*)3VWDLQLQJORZHUSDQHOGLUHFW*)3IOXRUHVFHQFH6FDOHEDUȝPb, Immunostaining for GFP (red) and 
Keratin 14 (K14; green) revealed strong GFP expression in the isthmus region, which contains epSCs that feed 
LQWRWKHHSLGHUPLVDQGVHEDFHRXVJODQGV6FDOHEDUȝP%XEXOJH6*VHEDFHRXVJODQG,VWLVWKPXV8,





















































































































Supplementary Figure 4: GFP/venus expression changes in a circadian manner. 
a, b&RPSDULVRQRIYHQXVPHDQIOXRUHVFHQFHLQWHQVLW\LQĮLQWHJULQbright/CD34+ bulge (aDQGĮLQWHJULQbright
/CD34- epidermal cells (b) from P27 Per1-venus mice kept under LD and DD conditions (one representative FACS 
profile is shown at CT6 and CT18 from each group; the gate to separate venusbright from venusdim cells was placed 
in all profiles according to the time point of brightest venus fluorescence intensity at CT12). The graph in b shows 
TXDQWLILFDWLRQRIĮLQWHJULQbright/CD34- epidermal cells at 4 different time points by FACS (mean ± s.e.m.; n = 2). 
White and black bars represent subjective day and night. c, Timelapse confocal imaging of telogen backskin of 
Per1-venus mice reveals an increase in venusbright nuclei in the bulge during the subjective night (from ZT13 to 
=7DUURZV6FDOHEDUȝP*UDSKVKRZVTXDQWLILFDWLRQRIPHDQIOXRUHVFHQFHLQWHQVLW\RIYHQXVbright nuclei in 














































Chromatin immunoprecipitation from sorted _6bfright/CD34+ bulge cells
Real time PCR from sorted _6bfright/CD34+ bulge cells
































































































































































Supplementary Figure 5:  Bmal1 modulates the response of epidermal cells to activation and dormancy 
cues.
a,  ChIP from tail epidermis of Bmal1WT mice revealed binding of Bmal and Clock to E-box and E-box-like 
elements in the promoters of genes involved in adhesion, cell cycle, Notch, TGF-` and Wnt pathways. ChIP for 
Bmal1 and Clock in 2 regions of the circadian-regulated gene Dbp was used as positive (P, promoter) and nega-
tive control (Ex3, exon 3). (n = 3, mean ± s.e.m.). b, ChIP from FACS-purified bulge cells of Bmal1WT mice shows 
strong binding of Bmal to the promoters of genes highly expressed in the bulge SC compartment (n = 2; mean ± 
s.e.m.). Graphs in a and b show the percentage of immunoprecipitated DNA over the input. c, The differential 
expression of adhesion, Wnt and TGF-` pathway genes in primary keratinocytes isolated from newborn Bmal1WT 
(WT) and Bmal1KO mice (KO) was not statistically significant. Fold-change values are displayed as relative 
expression to Bmal1WT cells at 0h after normalization to Pumilio1 (Pum1) (n = 3). Results are shown as mean ± 
s.e.m., * p < 0.05 (two-way ANOVA with Bonferroni post-test).  d, Real time PCR of adhesion, cell cycle, Wnt and 
TGF-` pathway genes in FACS purified bulge cells of 9-month-old Bmal1WT (WT) and Bmal1KO mice (KO) at 
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Supplementary Figure 6: Conditional deletion of Bmal1 in the epidermis. 
a,PPXQRVWDLQLQJIRU.HUDWLQJUHHQWRPDUN&UHH[SUHVVLQJFHOOVLQWKHHSLGHUPLV6FDOHEDUȝPb,
Efficiency of LoxP recombination in the epidermis of K14Cre/Bmal1LoxP/LoxP (Bmal1KO) mice was assessed by PCR 
from genomic DNA of epidermal cells (left panel; lane 1, conditional allele; lane 2, Wt allele; lane 3, recombined 
allele) and by western blot for Bmal1 in keratinocytes isolated from Bmal1WT or Bmal1KO mice (right panel; 
arrow). c, Conditional deletion of Bmal1 effects the expression of venus in the epidermis of Bmal1KO/Per1-venus 
mice. Quantification of venusbright and venusdimFHOOVLQWKHĮLQWHJULQbright&'EXOJHDQGĮLQWHJULQbright/CD34-






































TOP-Flash luciferase assay 
Supplementary Figure 7: Primary mouse keratinocytes did not respond to activation through canonical 
Wnt signaling. 
Primary mouse keratinocytes of Bmal1WT and Bmal1KO mice transfected with TOP-Flash and FOP-Flash 
reporter plasmids were incubated for 24 hours in the absence or the presence of the canonical Wnt small molecu-
































































































































































Supplementary Figure 9: Clock perturbation in vivo results in changes in the number of dormant bulge 















































































































Supplementary Figure 10: Clockhigh epidermal keratinocytes have an increased clonogenic potential. 
a, b, &ORQRJHQLFDVVD\RI)$&6SXULILHGĮLQWHJULQbright/ CD34- epidermal keratinocytes from the backskin of (a)






























































































Supplementary Figure 11: Percentage of bulge stem cells is not altered in Bmal1KO and Per1/2dKO mice. 
a, b, )$&6DQDO\VLVRIĮLQWHJULQbright/CD34+ bulge cells of (a) Bmal1WT and Bmal1KO mice or (b) Per1/2dKO 
mice and wildtype (WT) control animals show no differences in the percentage of bulge stem cells in 6-week-old 
animals (n = 4). Results are shown as mean ± s.e.m.; statistical significance was assessed by two-tailed Student’s 








Supplementary Figure 12: Bmal1KO and Per1/2dKO mice show opposite phenotypes with regard to 
epidermal proliferation. 
Whole mount immunostaining for the proliferation marker Ki67 shows lower expression of Ki67 in the epidermis of 
Bmal1KO mice compared to Bmal1WT mice, and enhanced expression in the epidermis of Per1/2dKO mice with 
UHJDUGWRWKHLUZLOGW\SHFRQWUROV6FDOHEDUVȝP8SSHUSDQHOXQVSHFLILFVWDLQLQJLQVHEDFHRXVJODQGVZDV












Supplementary Figure 13: Analysis of aged Bmal1KO mice for the expression of p16, p19 and apoptosis. 
Immunohistochemistry for p16 in 10-12-month-old Bmal1WT and Bmal1KO mice revealed enhanced expression of 
p16 in the epidermis and hair follicles of Bmal1KO mice. Cells positively stained for p19 (black arrows) were only 
occasionally observed in Bmal1WT and Bmal1KO mice in similar numbers. Similarly, apoptotic cells (Tunnel; 
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Supplementary Figure 14: Validation of microarray data comparing aged BMAL1WT and BMAL1KO mice. 
a, c, d, 9DOLGDWLRQRIPLFURDUUD\GDWDLQ)$&6LVRODWHGĮLQWHJULQbright/CD34- epidermal cells from Bmal1KO and 
Bmal1WT mice by real time PCR (n = 2-3, for each group) shows differential expression of (a) several core 
circadian genes, (c) genes implicated in cell cycle, DNA damage and terminal differentiation and (d) the 
abundance of the pri-miRNAs 23b, 27b and 24-1. Fold-change values are displayed as relative expression to 
Bmal1WT cells after normalization to Pumilio1 (Pum1), or 18S-rRNA. Results are shown as mean ± s.e.m., * p < 




































Supplementary Figure 15: Loss of Bmal1 reduces the development of squamous tumors. 
a, Bmal1KO/K5-SOS mice developed fewer neoplastic lesions compared to Bmal1WT/K5-SOS littermates at early 






















































































Supplementary Figure 17: Gating strategy for FACS analysis of K5-SOS induced tumors. Viable cells were 
selected by DAPI exclusion (gate 1), contaminating fibroblasts were excluded by forward and side scatter (gate 2), 
doublets were discarded in gate 3, epithelial cells were selected in gate 4 by a combination of a lineage negative 
PDUNHUVLQ3(&'&'DQG&'DDQGDSRVLWLYHPDUNHU(SFDP$3&&\DQGĮbright/CD34+ tumor-



























CACGTG/ CACGTG- 4839/ -177 Promoter/ Promoter yes/ no
Promoter/ Promoter yes/ no11 - 4687/ - 3945 CACGTG/ CACCTG










Promoter/ Promoter no/ yes
7
- 2940/ - 400 CACGTG/ CACGTG
CACGTG/ CACGTG- 2533/ - 1410 Promoter/ Promoter
11
no/ no1
CACGTG/ CACGTG/ CACGTG- 4917/ - 4468/ - 4098 Promoter/ Promoter/ Promoter3 yes/ no/ no
Promoter/ Intron 1 CACCTG/ CACGCG- 2797/ + 262 no/ no
Promoter no- 2596 AACGTG
CACGTG/ CACGTG/ CACGTG- 3243/ - 2501/ - 490 Promoter/ Promoter/ Promoter no/ no/ no
AACGTG/ AACGTG- 2842/ - 1247 Promoter/ Promoter15 no/ no
AACGTG- 361 Promoter11 yes




Promoter yes- 2687 CACGTG




Bmpr1a AACGTG- 4916 Promoter14 no
Foxo3a CACGTG- 2435 Promoter10 no
CACGTG/ AACGTG- 656/ - 442 Promoter/ Promoter yes/ no
CACGTG/ CACGTG- 11/ + 186 Promoter/ Exon1 no/ no
Notch pathway
 Adhesion/ Cell cycle/ others
Itga6
Cdk4 10
AACGTG/ AACGTG- 4760/ - 3064 Promoter/ Promoter2 no/ no
- 251/ - 197/ -177
CACGTG/ AACGTG- 1689/ + 150 Promoter/ Exon1 no/ yes
CACGTG/ AACGTG- 90/ + 414 no/ yesPromoter/ Intron 1
CACGTG/ CACGTG/ CACGTG yes/ yes/ yesPromoter/ Promoter/ Promoter
Sox9 AACGTG- 44 Promoter11 yes
Lhx2 CCCGTG/ CACGTG/ AACGTG- 4668/ -2591/ - 2040 yes/ no/ no2 Promoter/ Promoter/ Promoter
Gene promoters analyzed, but  no binding sites for Bmal/ Clock found:
Delta1, Filaggrin, Fzd3, Gli2, Hey1, Involucrin, Jagged1, Lgr5, Ltbp2, Ltbp3, Ltbp4, Nfatc1, Notch1, Sfrp1, Smurf1, Tcf3

Supplementary Table 4 
Real time PCR primer 








































Supplementary Table 5 
Chromatin immunoprecipitation primer 
Gene Primer name Forward Reverse 
Dbp Dbp_P ACACCCGCATCCGGTAGC CCACTTCGGGCCAATGAG
Dbp Dbp_E3 CGTGGAGGTGCTTAATGACCTTT CATGGCCTGGAATGCTTGA
Dbp primer (Ripperger et al., 2006)49
Wnt3 Wnt3_UP CAACCCCTTTGCTTTCTAG GACACCCCCTTCCCAGTC
Lef1 Lef1_farUP1 CAGTGTACTGTAACAGTG CTTCTTCCAGCCTGCTTC
Dab2 Dab2_farUP CACTATGGAAAACGGGAC CTCTTTGTTATTACACTTC
Dab2 Dab2_UP GAACCAGGACTGCACACT GGAGGACACAAAAGCATC
Notch2 Notch2_farUP CACTCCAACAATTCAACAG ACCCAACTTTAACTTCTG
Itga6 Itga6_E1 GCTTCTAGCCCGGCTGGG GAACTCACAGCCGCTTGTC
Cdk4 Cdk4_UP1 CTTGTGCTCCACCCTCTC CTGACGGCCACGTGACCTG
Cdk4 Cdk4_I1 GTGATCCTCTTTGTGCCTAG GCCAACGCGATCAGCAAC
Lhx2 Lhx2-farUP1 CAGATCGCTGCAGGGAGAAG GGTCATACCATACAGAGAT
Tcf4 Tcf4_farUP CCAAGAAGTCTGCGGTGA CCAGCGATCATTAGTTACC
Fzd2 Fzd2_farUP GCTCTTGTACCTCAGAGG GCTCAGTCCGTGATTGCT
Smad7 Smad7_farUP GGACATCAGCTCTGAATC AGGCTGGTATGATGATGG
Lefty Lefty_UP GCAGAGAACGTGAGACCTC TGTTAGCCATATACTTCACC
Dkk3 Dkk3_UP TGCTGCAACGGACAGACC CTCTCCGCATCTCCTGATC
Sox9 Sox9_UP ATCCGGTCCAATCAGCGAC CTCTCCGACTTCCAGCTCAG


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